MondayAug 20, 2012 8:19 am

NB Manufacturing, Inc. (NBMF) Subsidiary Unveils AdBlind™ Targeted Advertising and Monetization Platform

Xhibit LLC, a wholly owned subsidiary of NB Manufacturing, announced Friday that it has released its exclusive advertising platform, AdBlind™. The platform was created by Xhibit’s technology group to help app developers, businesses, marketers, and advertisers monetize their customers more effectively, as well as improve their digital IP. AdBlind™, a unique Software-as-a-Service advertising product, serves these functions while simultaneously connecting advertisers to numerous marketing channels. AdBlind’s innovative feature set includes the capability for third party advertisers to embed AdBlind™ advertisements inside of a client’s own marketing, social, and mobile communications. This feature will develop an entirely new channel for shared…

Continue Reading

FridayAug 17, 2012 3:44 pm

ERF Wireless, Inc. (ERFB) Posts Q2 Sales Improvements with Boost from Oil & Gas Subsidiary

ERF Wireless, a provider of enterprise-class wireless and broadband products and services, today reported its second-quarter financial results, with improvements reflecting the company’s aggressive growth strategy of expanding its services in the oil and gas industry. Second-quarter revenues came in at $1.68 million, an increase of 29 percent as compared to revenues of $1.31 million reported for the second quarter of the year prior. The overall increase includes a $380,000 increase in the company’s oil and gas operations subsidiary, Energy Broadband Inc. Energy Broadband reported revenues of $1.02 million for the second quarter of 2012, an increase of 59 percent…

Continue Reading

FridayAug 17, 2012 3:07 pm

International Stem Cell Corp. (ISCO) Highlighted by Seeking Alpha Article as Biotech with Strong Lead in Regenerative Stem Cell Therapy for Parkinson’s

International Stem Cell was listed first among emerging biotech alternatives in an article over at Seeking Alpha that showcased stem cell technology and other improved solutions to the largely ineffective 'band-aid' drug-based offerings currently out there for treating Parkinson's. The devastating degenerative neurological disease is now estimated to be affecting a staggering 1M Americans alone (7-10M globally), with another 60k domestic cases diagnosed every year. ISCO is on the cutting-edge of stem cell therapeutics development, with a rich portfolio of regenerative medicine technologies. The company's recent (July 18) disclosure that they will be taking the Parkinson’s Disease Program to the…

Continue Reading

FridayAug 17, 2012 2:19 pm

Longhai Steel, Inc. (LGHS) is “One to Watch”

Longhai Steel is a leading producer of high-quality steel wire in eastern China, with annual capacity of 1.5 million metric tons. Longhai's wire is manufactured into screws, nails, and wire mesh used for fencing and to reinforce concrete. Longhai recently expanded its production facility to include specialized applications such as steel wire rope, steel strand, steel belted radial tires, and steel welding rod. Longhai Steel is headquartered in Xingtai, Hebei province, the People's Republic of China. The company's competitive advantages are its advanced production equipment and process technology, high product quality, expedited production, and close proximity to distributors and end…

Continue Reading

FridayAug 17, 2012 12:27 pm

USA Recycling Industries, Inc. (USRI) Sees Used Tires and Other Scrap Material as a Mission

With what is estimated to be well over 200 million vehicles on the road in the U.S. alone, one can imagine the volume of tires being replaced on an annual basis. Hundreds of millions of tires are scrapped every year in the U.S., and, in spite of private and governmental efforts, millions of them still end up in landfills. And that’s a problem, because tires are designed to be tough and long lasting, not easily broken down, plus they capture empty space, increasing their discard volume. It’s a special tragedy, since tires can now be recycled into many things, including…

Continue Reading

FridayAug 17, 2012 10:54 am

Teletouch Communications, Inc. (TLLE) Sells Two-Way Radio Business, Focuses on Broader Cellular and Electronics Distribution

With its start as a Motorola Service Station in east Texas, Teletouch and its predecessor companies have been known for nearly a half century as providers of two-way radio products and services, eventually including cellular, GPS-telemetry, and wireless messaging, and operating a chain of 11 retail and authorized agent stores in North and Central Texas. Today, with its developing presence as a cellular and electronics wholesale distributor, the company has chosen to divest its two-way radio division. Yesterday, Teletouch announced the sale of its two-way radio and public safety equipment business unit for approximately $1.5 million to DFW Communications, Inc.,…

Continue Reading

FridayAug 17, 2012 8:45 am

Arotech Corp. (ARTX) Subsidiary Awarded Contract to Supply National Guard Driving Simulators

FAAC, a subsidiary of Arotech, recently announced that the company has been awarded a $6.1 million contract to supply the Army National Guard with Military Operator Driving Simulators (ODS). Under the terms of the contract, FAAC will supply eight trailer systems to the National Guard. Arotech is focused on developing and manufacturing simulation-based training systems as well as multimedia and interactive digital solutions for use in engineering, use-of-force, and driver training simulations for military, law enforcement, security, municipal, and private industry personnel. The National Guard locations receiving the simulators are Arizona, Indiana, Kansas, Kentucky, Massachusetts, South Dakota, and Nevada. Each…

Continue Reading

ThursdayAug 16, 2012 3:42 pm

TG Therapeutics, Inc. (TGTX) and Rhizen Pharmaceuticals Announce Partnership to Co-Develop and Commercialize TGR-1202

TG Therapeutics is a clinical-stage biopharm company whose strategy is to acquire, develop, and commercialize pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. In line with this strategy, TG and Rhizen Pharmaceuticals S A today announced their exclusive global agreement to co-develop and commercialize Rhizen's lead product candidate, TGR-1202. "We are excited to enter into this collaboration with Rhizen Pharmaceuticals, whose innovative pre-clinical development program has yielded an impressive portfolio of PI3K delta inhibitors that we are eager to advance into development," Michael S. Weiss, executive chairman and Interim CEO of TG stated in the press…

Continue Reading

ThursdayAug 16, 2012 3:21 pm

Silver Bull Resources, Inc. (SVBL) Renews Mitzic License, Reports on Extensive Iron Ore Correlated by Recent Work Program

Silver Bull Resources, the Canadian mineral exploration firm primarily focused on their flagship Sierra Mojada (silver, zinc, and lead) project in Mexico, reported some really good news today out of their 1,243 sq. mile Mitzic site, which is on the western edge of the region’s major iron belt (three deposits greater than 650 metric tonnes at 60% Fe currently under development), in the French-speaking West-Central African democracy of Gabon – as the Gabonese Ministry of Mines renewed the site license for another three years. In addition, the company offered a pertinent status update from the work program conducted on the…

Continue Reading

ThursdayAug 16, 2012 2:32 pm

Oncolytics Biotech, Inc. (ONCY) Completes Patient Enrollment in UK Phase I Trial of REOLYSIN

Canadian-based Oncolytics Biotech is focused on the novel approach of developing oncolytic viruses as potential therapeutics for patients afflicted with various types of cancer, including lung, pancreatic, and colorectal cancers. The company's clinical program includes a Phase III trial in head and neck cancer using REOLYSIN, its proprietary formulation of the human reovirus. The company today announced that it has completed its 36 patient enrollment in its U.K. Phase I clinical trial using intravenously-administered REOLYSIN in combination with cyclophosphamide in patients with advanced malignancies. Eligible patients include those who have been diagnosed with advanced or metastatic solid tumors. These include…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered